本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Cidara Therapeutics, Inc.

21.90
-0.0800-0.36%
盘后21.900.00000.00%16:00 EDT
成交量:14.75万
成交额:323.31万
市值:2.40亿
市盈率:-0.82
高:22.82
开:22.12
低:21.23
收:21.98
数据加载中...
2022/03/07

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/07

重要事件披露

8-K - Current report
2022/03/07

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/04

重要事件披露

8-K - Current report
2022/02/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/12/14

重要事件披露

8-K - Current report
2021/11/18

SEC问询函

CORRESP [Cover] - Correspondence
2021/11/15

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/15

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/09/21

重要事件披露

8-K - Current report
2021/09/01

重要事件披露

8-K - Current report
2021/08/31

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/08/17

重要事件披露

8-K - Current report
2021/08/12

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/08/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]